Neoadjuvant Therapy in Breast Cancer Challenges and Recommendations
November 2, 2013
The main issues that will be addressed are the controversy of is neoadjuvant therapy appropriate for early stage breast cancer and the radiation recommendations in the setting of down-staged disease. The current radiation recommendation are based on stage before systemic therapy which might or might not be appropriate and using neoadjuvant treatment for early stage breast cancer is still controversial and the activity might shed some light on new studies/recommendations. It is our hope that providing evidence to support early stage cancer and evidence to, perhaps, base radiation recommendations on the post neoadjuvant stage will change amongst the many variables that are causing this issue.
- Medical Oncologist
- Radiation Oncologist
- Surgical Oncologist
- Physician Assistant
- Nurse Practitioner
- Oncology Nurse
To address the controversial issues, recommendations and challenges of neoadjuvant therapy with the treatment of breast cancer.
Milwaukee Marriott Downtown
323 E. Wisconsin Avenue
A block of rooms has been reserved for Nov. 1 & 2 at the Milwaukee Marriott Downtown,
323 E. Wisconsin Ave., Milwaukee, WI for a special rate of $149 per night. To reserve your room, call the Marriott at (414) 278-5999. Rooms are available on a first come first serve basis.
Terry P. Mamounas, MD, MPH, FACS
Medical Director of the Comprehensive Breast Cancer Program at MD Anderson Cancer Center, Orlando and Professor of Surgery at Northeast Ohio Medical University. He is also Chairman of the Breast Committee at the National Surgical Adjuvant Breast and Bowel Project (NSABP) in Pittsburgh, Pennsylvania and Co-Chair of the NRG Oncology Breast Committee.
Harry D. Bear, MD, PhD
Walter Lawrence, Jr. Distinguished Professor in Oncology, Chairman of the Division of Surgical Oncology, Professor of Surgery and Microbiology and Immunology, and Medical Director of Massey
Cancer Center’s Breast Health Center at Virginia Commonwealth University. He is also the Interim Medical Director of Clinical Research Operations for the Massey Cancer Center.
Julia White, MD, FACR
Vice Chair of Clinical Research and Director of Breast Radiation Oncology Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center. No relevant financial relationships to disclose.
Hanadi Bu-Ali, MD
Breast Surgical Oncologist and Chair, Breast Program Leadership Team, Wheaton Franciscan Medical Group, Milwaukee, Wisconsin. No relevant financial relationship to disclose.
- 4.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 4.00 Hours of ParticipationHours of Participation credit.